| Schedule of stock-based compensation
pro rata |
|
|
|
| |
|
At March 31, 2026
|
|
| Grant date share price |
|
$ |
6.86 |
|
| Grant date exercise price |
|
$ |
5.83 |
|
| Expected term |
|
|
0.5 years |
|
| Expected volatility |
|
|
76.29 |
% |
| Risk-free rate |
|
|
3.70 |
% |
| Expected dividend rate |
|
|
0 |
% |
During the offer period, the Company records stock-based
compensation pro rata as an expense and a credit to additional paid-in capital. The following table discloses relevant information for
the ESPP at March 31, 2026 and for three months then ended.
| Schedule of relevant information for ESPP |
|
|
|
| |
|
At
March 31, 2026 |
|
| Cash payment received from employee withholding |
|
$ |
33,538 |
|
| Cash from employee withholdings used to purchase shares under ESPP |
|
|
— |
|
| Accrued employee withholdings at March 31, 2026 |
|
$ |
33,538 |
|
| |
|
|
|
| |
|
For the Three Months ended
March 31, 2026 |
|
| Cash from employee withholding used to purchase ESPP shares |
|
$ |
— |
|
| Stock based compensation expense |
|
|
16,318 |
|
| Total increase to equity for year ended March 31, 2026 |
|
$ |
16,318 |
|
|